GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » HealthLynked Corp (OTCPK:HLYK) » Definitions » Peter Lynch Fair Value

HealthLynked (HealthLynked) Peter Lynch Fair Value : $-0.24 (As of May. 26, 2024)


View and export this data going back to 2017. Start your Free Trial

What is HealthLynked Peter Lynch Fair Value?

Peter Lynch Fair Value applies to growing companies. The ideal range for the growth rate is between 10 - 20% a year. Peter Lynch thinks that the fair P/E value for a growth company equals its growth rate, that is PEG = 1. The earnings here is trailing twelve month (TTM) earnings. For non-bank companies, the growth rate we use is the average growth rate for EBITDA per share over the past 5 years. For Banks, the growth rate we use is the average growth rate for Book Value per share over the past 5 years. If 5-Year Growth Rate is greater than 25% a year, we use 25. If 5-Year Growth Rate is smaller than 5% a year, we do not calculate Peter Lynch Fair Value.

Here, as of today, HealthLynked's PEG is 1. HealthLynked's 5-Year TTM EBITDA Growth Rate is 20.29. HealthLynked's EPS without NRI for the trailing twelve months (TTM) ended in Mar. 2024 was $-0.01. Therefore, the Peter Lynch Fair Value for today is $-0.24.

As of today (2024-05-26), HealthLynked's share price is $0.05. HealthLynked's Peter Lynch fair value is $-0.24. Therefore, HealthLynked's Price to Peter Lynch Fair Value Ratio for today is N/A.


The historical rank and industry rank for HealthLynked's Peter Lynch Fair Value or its related term are showing as below:



HLYK's Price-to-Peter-Lynch-Fair-Value is not ranked *
in the Healthcare Providers & Services industry.
Industry Median: 1.345
* Ranked among companies with meaningful Price-to-Peter-Lynch-Fair-Value only.

Note: Please don't confuse Peter Lynch Fair Value with the value reached in Peter Lynch Chart.


HealthLynked Peter Lynch Fair Value Historical Data

The historical data trend for HealthLynked's Peter Lynch Fair Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

HealthLynked Peter Lynch Fair Value Chart

HealthLynked Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Peter Lynch Fair Value
Get a 7-Day Free Trial - - - - -

HealthLynked Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Peter Lynch Fair Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of HealthLynked's Peter Lynch Fair Value

For the Medical Care Facilities subindustry, HealthLynked's Price-to-Peter-Lynch-Fair-Value, along with its competitors' market caps and Price-to-Peter-Lynch-Fair-Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


HealthLynked's Price-to-Peter-Lynch-Fair-Value Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, HealthLynked's Price-to-Peter-Lynch-Fair-Value distribution charts can be found below:

* The bar in red indicates where HealthLynked's Price-to-Peter-Lynch-Fair-Value falls into.



HealthLynked Peter Lynch Fair Value Calculation

HealthLynked's Peter Lynch Fair Value for today is calculated as

Peter Lynch Fair Value=PEG Ratio*5-Year TTM EBITDA Growth Rate***EPS without NRI (TTM)
=1* 20.29 *-0.012
=-0.24

HealthLynked's EPS without NRI for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.01.


* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** Please be aware that the 5-Year TTM EBITDA Growth Rate is calculated based on TTM data over the last 5 years. For quarterly reported companies, the TTM data adds up the quarterly data reported by the company within the most recent 12 months. For companies that report semi-annually, annually, or do not have enough quarterly data, GuruFocus uses the annual data as the TTM data.

If 5-Year Earnings Growth Rate is greater than 25% a year, we use 25.

If 5-Year Earnings Growth Rate is smaller than 5% a year, we do not calculate Peter Lynch Fair Value.

Please note that we use the 5-year average growth rate of EBITDA per share as the growth rate for non-bank companies, as EBITDA growth is subject to less manipulations than net earnings per share. For banks, we use the 5-year average growth rate of Book Value per share as the growth rate. The reason is that EBITDA is not applicable to Banks and Book value is a relative important measurement for Banks. In the calculation, PEG=1 because Peter Lynch thinks that the fair P/E ratio of the growth stock is equal to its earnings growth rate.


HealthLynked  (OTCPK:HLYK) Peter Lynch Fair Value Explanation

Peter Lynch Fair Value applies to growing companies. The ideal range for the growth rate is between 10 - 20% a year.

Peter Lynch thinks that the fair P/E value for a growth company equals its growth rate, that is PEG = 1. The earnings here is trailing twelve month (TTM) earnings. For non-bank companies, the growth rate we use is the average growth rate for EBITDA per share over the past 5 years. For Banks, the growth rate we use is the average growth rate for Book Value per share over the past 5 years.

Please don't confuse Peter Lynch Fair Value with the value reached in Peter Lynch Chart. In Peter Lynch chart, a fixed P/E ratio of 15 is used to draw the Earnings Line. Therefore the value reached has a P/E ratio of 15. But in Peter Lynch Fair Value calculation, P/E equals to the growth rate of EBITDA per share over the past 5 years, which is 20.29 instead of 15 in this case.

HealthLynked's Price to Peter Lynch Fair Value Ratio for today is calculated as

Price to Peter Lynch Fair Value=Share Price/Peter Lynch Fair Value
=0.05/-0.24
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


HealthLynked Peter Lynch Fair Value Related Terms

Thank you for viewing the detailed overview of HealthLynked's Peter Lynch Fair Value provided by GuruFocus.com. Please click on the following links to see related term pages.


HealthLynked (HealthLynked) Business Description

Traded in Other Exchanges
N/A
Address
1265 Creekside Parkway, Suite 302, Naples, FL, USA, 34108
HealthLynked Corp operates a cloud-based online personal medical information and records archiving system for patients and doctors to keep track of medical information via the Internet in a cloud-based system. It operates in four segments: Health Services, Digital Healthcare, ACO/MCO, and Medical Distribution. The majority of its revenue is generated from the Health Services segment, which is into operations of Naples Women's Center, Naples Center for Functional Medicine, and Bridging the Gap Physical Therapy.
Executives
Robert P Gasparini director 12701 COMMONWEALTH DRIVE, SUITE 9, FORT MYERS FL 33913
Daniel L. Hall director C/O HEALTHLYNKED CORP., 1035 COLLIER CENTER WAY SUITE 3, NAPLES FL 34110
Heather Monahan director 520 WEST AVE., #1704, MIAMI BEACH FL 33139
Paul Hobaica director 1265 CREEKSIDE PARKWAY, SUITE 302, NAPLES FL 34108
Robert P. Mino director 1072 LAKESHORE DR., JUPITER FL 33458
George O'leary director, officer: Chief Financial Officer C/O ISONICS CORPORATION, 5906 MCINTYRE STREET, GOLDEN CO 80403
Michael T Dent director, 10 percent owner, officer: Chief Executive Officer 12701 COMMONWEALTH DRIVE, SUITE 9, FORT MYERS FL 33913